INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.

Slides:



Advertisements
Similar presentations
Surviving Survival Analysis
Advertisements

If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Statistical Analysis and Data Interpretation What is significant for the athlete, the statistician and team doctor? important Will Hopkins
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Statistical Issues in Contraceptive Trials
Confidence Intervals © Scott Evans, Ph.D..
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Analysis of Time to Event Data
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Main Points to be Covered
Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.
M2 Medical Epidemiology
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Using time-dependent covariates in the Cox model THIS MATERIAL IS NOT REQUIRED FOR YOUR METHODS II EXAM With some examples taken from Fisher and Lin (1999)
Introduction to Survival Analysis Seminar in Statistics 1 Presented by: Stefan Bauer, Stephan Hemri
Inferences About Process Quality
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Survival Analysis A Brief Introduction Survival Function, Hazard Function In many medical studies, the primary endpoint is time until an event.
Analysis of Complex Survey Data
Survival Analysis: From Square One to Square Two
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
Introduction to Survival Analysis August 3 and 5, 2004.
INTRODUCTION TO CLINICAL RESEARCH Scientific Concepts for Clinical Research Karen Bandeen-Roche, Ph.D. July 12, 2010.
Estimating cancer survival and clinical outcome based on genetic tumor progression scores Jörg Rahnenführer 1,*, Niko Beerenwinkel 1,, Wolfgang A. Schulz.
01/20141 EPI 5344: Survival Analysis in Epidemiology Quick Review and Intro to Smoothing Methods March 4, 2014 Dr. N. Birkett, Department of Epidemiology.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
NASSER DAVARZANI DEPARTMENT OF KNOWLEDGE ENGINEERING MAASTRICHT UNIVERSITY, 6200 MAASTRICHT, THE NETHERLANDS 22 OCTOBER 2012 Introduction to Survival Analysis.
Survival Data John Kornak March 29, 2011
G Lecture 121 Analysis of Time to Event Survival Analysis Language Example of time to high anxiety Discrete survival analysis through logistic regression.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Lecture 3 Survival analysis.
Statistical approaches to analyse interval-censored data in a confirmatory trial Margareta Puu, AstraZeneca Mölndal 26 April 2006.
Time-dependent covariates and further remarks on likelihood construction Presenter Li,Yin Nov. 24.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
HSRP 734: Advanced Statistical Methods July 31, 2008.
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients with Locoregional Esophageal Carcinoma, Ursa et al. Statistical Methods:
CREATE Biostatistics Core THRio Statistical Considerations Analysis Plan.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 6: “Number Needed to Treat” to Prevent One Case.
Medical Statistics as a science
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
INTRODUCTION TO CLINICAL RESEARCH Introduction to Statistical Inference Karen Bandeen-Roche, Ph.D. July 12, 2010.
Satistics 2621 Statistics 262: Intermediate Biostatistics Jonathan Taylor and Kristin Cobb April 20, 2004: Introduction to Survival Analysis.
Biostatistics Case Studies 2014 Youngju Pak Biostatistician Session 5: Survival Analysis Fundamentals.
Statistical inference Statistical inference Its application for health science research Bandit Thinkhamrop, Ph.D.(Statistics) Department of Biostatistics.
Biostatistics Case Studies 2007 Peter D. Christenson Biostatistician Session 2: Aging and Survival.
01/20151 EPI 5344: Survival Analysis in Epidemiology Quick Review from Session #1 March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health &
Some survival basics Developments from the Kaplan-Meier method October
01/20151 EPI 5344: Survival Analysis in Epidemiology Hazard March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
SS- 1 Use of Clozaril ® and Zyprexa ® as Concomitant Medication (Simultaneous Use)  69 Clozaril patients used Olanzapine as concomitant medication  17.
Topic 19: Survival Analysis T = Time until an event occurs. Events are, e.g., death, disease recurrence or relapse, infection, pregnancy.
02/20161 EPI 5344: Survival Analysis in Epidemiology Hazard March 8, 2016 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Aron Goldhirsch, Richard.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
03/20161 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 29, 2016 Dr. N. Birkett, School of Epidemiology, Public Health.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
1 Analysis of Survival Data with Demographic Applications (Spring term 2006) Lecture 3: Non-Parametric Comparison of two or more Survival Curves.
Survival curves We know how to compute survival curves if everyone reaches the endpoint so there is no “censored” data. Survival at t = S(t) = number still.
Measures of Disease Occurrence
Kaplan-Meier survival curves and the log rank test
Presentation transcript:

INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010

Acknowledgements Scott Zeger Marie Diener-West ICTR Leadership / Team July 2010JHU Intro to Clinical Research2

Introduction to Survival Analysis 1.Thinking about times to events; contending with “censoring” 2.Counting process view of times to events 3.Hazard and survival functions 4.Kaplan-Meier estimate of the survival function 5.Future topics: log-rank test; Cox proportional hazards model

“Survival Analysis” Approach and methods for analyzing times to events Events not necessarily deaths (“survival” is historical term) Need special methods to deal with “censoring”

Typical Clinical Study with Time to Event Outcome StartEnd EnrollmentEnd Study Calendar time Loss to Follow-up Event

Switching from Calendar to Follow-up Time Follow-up time >3 5 >8 1 >6

The Problem with Standard Analyses of Times to Events Mean: ( )/5 = right? Median: 5 – right? Histogram

Censoring > 3 is not 3, it may be 33 Mean is not 4.6, it may be ( )/5 = 10.6 Or any value greater than 4.6 > 3 is a right “censored value” – we only know the value exceeds 3 > x is often written “x+”

9 Uncensored data: The event has occurred –Event occurrence is observed Censored data: The event has yet to occur –Event-free at the current follow-up time – A competing event that is not an endpoint stops follow-up –Death (if not part of the endpoint) –Clinical event that requires treatment, etc. –Our ability to observe ends before event happens Censoring

Contending with Censored Data Standard statistical methods do not work for censored data We need to think of times to events as a natural history in time, not just a single number Issue: If no events are reported in the interval from last follow-up to “now”, need to choose between: No news is good news? No news is no news?

11 One Option: Overall Event Rate Example: 2 events in 23 person months = 1 event per 11.5 months = 1.04 events per year = 104 events per 100 person-years Gives an average event rate over the follow-up period; actual event rate may vary over time For a finer time resolution, do the above for small intervals

Switching from Calendar to Follow-up Time Follow-up time >3 5 >8 1 > person months of observation; 2 actual events

Second Option: Natural history “One day at a time” Follow-up time >3 5 >8 1 >

Thinking about Times to Events Interval of follow-up Event Times No. at risk Fraction of events=“hazard”

Survival Function “Survival function”, S(t), is defined to be the probability a person survives beyond time t S(0) =1.0 S(t+1)S(t)

Hazard Function Hazard at time t, h(t), is the probability per unit time of having the event in a small interval around time t Force of mortality ~ Pr{event in (t,t+dt)}/dt Need not be between 0 and 1 because it is per unit time h(t) ~ {S(t)-S(t+dt)}/{S(t) dt}

17 Basic idea: Live your life one interval (day, month, or year) at a time Example: S(3)= Pr(survive for 3 months) = Pr(survive 1st month) × Pr(survive 2nd month | survive 1st month) × Pr(survive 3rd month | survive 2nd month) Thus, = Pr(survive for 1st month & 2 nd & 3 rd ) Hazard Function

18 Estimating the Survival Function: Kaplan-Meier Method Interval of Follow-Up Times No. at risk No of events Fraction of events=“hazard” Fraction without event in interval Fraction without event since start Pr(survive past 5) = Pr(survive past 5|survive past 4) *Pr(survive past 4) [ = Pr(survive past 5 and survive past 4) ]

Displaying the Survival Function

Notes on Estimating Survival Function Estimate only changes in intervals where an event occurs Censored observations contribute to denominators, but never to numerators Intervals are arbitrary; want narrow ones Kaplan-Meier estimate results from using infinitesimal interval widths

Acute Myelogenous Leukemia Example Data: 5,5,8,8,12,16+, 23, 27, 30+, 33, 43,

Kaplan-Meier Estimate of S(t) – AML Data Event Times At risk # of Events # SurviveFraction Survive Estimate of S(t)

Graph of K-M Estimate of Survival Curve for AML Data

K-M Estimate for Risp/Halo Trial

Comparing Survival Functions Suppose we want to test the hypothesis that two survival curves, S1(t) and S2(t) are the same Common approach is the “log-rank” test It is effective when we can assume the hazard rates in the two groups are roughly proportional over time

26 Logrank test: “Drug trial” data Logrank: 1.72 p-value:.19 Conclusion: We lack strong support for a drug effect on survival

Comparing Survival Functions Suppose we want to test the hypothesis that two survival curves, S1(t) and S2(t) are the same Common approach is the “log-rank” test It is effective when we can assume the hazard rates in the two groups are roughly proportional over time Regression analysis—“Cox” model: more to come

28 Regression Analysis for Times to Events Cox proportional hazards model Hazard of an event is the product of two terms –Baseline hazard, h(t), that depends on time, t –Relative risk, rr(x) that depends on predictor variables, x, but not time Each person’s hazard varies over time in the same way, but can be higher or lower depending on their predictor variables x

29 Cox Proportional Hazards Model (t,x) = hazard for people at risk with predictor values x = (x 1,x 2, …..x p ) (t,x) = ln[ (t,x)] =

30 Cox Proportional Hazards Model Relative Hazard (hazard ratio) interpretation of the  ’s = relative risk for one unit difference in x 1 with same values for x 2, …. x p (at any fixed time t)

31 Cox Proportional Hazards Model Proportional hazards over time: (t;x) 0t x 1 =1 x 1 =0

Main Points Once Again Time to event data can be censored because every person does not necessarily have the event during the study Think of time to event as a natural history, that is 0 before the event and then switches to 1 when the event occurs; analysis counts the events Survival function, S(t), is the probability a person’s event occurs after each time t

Main Points Once Again Kaplan-Meier estimator of the survival function is a product of interval-specific survival probabilities Hazard function, h(t), is the risk per unit time of having the event for a person who is at risk (not previously had event) Logrank tests evaluate differences among survival in population subgroups Cox model used for regression for survival data